The Tamiflu Timeline

A timeline of key links and articles, in response to the drugs company Roche not publishing all clinical trial data on Tamiflu and more relating to the #AllTrials campaign.

byUK Cochrane Centre3 Likes2,651 Views
Favicon for
Favicon for

  1. 24th April 2014
  2. 17th April 2014
  3. 15th April 2014

    "The government will push ahead with its plan to spend £49m (€60m; $80m) replacing stocks of oseltamivir (Tamiflu) that are due to expire, so as to maintain its stockpile of antivirals in case of a flu pandemic." Ingrid Torjesen, The BMJ
  4. 14th April 2014
  5. 13th April 2014
  6. 11th April 2014
  7. 10th April 2014

    "This week sees the publication of the updated Cochrane systematic review on the neuraminidase inhibitors oseltamivir and zanamivir.1 The review, which is also reported in two papers published in The BMJ,2 3 provides the most complete analysis so far of what is known from randomised trials about the effectiveness and safety of these antiviral drugs." Elizabeth Loder, Clinical Editor, The BMJ; David Tovey, Editor-in-Chief, The Cochrane Library; Fiona Godlee, Editor-in-Chief, The BMJ
  8. "They also found worrying side-effects in people taking it to prevent flu, which had not been fully disclosed, including psychiatric and kidney problems. "There is no credible way these drugs could prevent a pandemic," said Carl Heneghan, professor of evidence-based medicine at Oxford University and one of the team. They are now calling for the WHO to review its advice to countries and for the UK government not to renew its stockpile when the drugs go out of date." Sarah Boseley, The Guardian
  9. "RCTs are the gold standard of drug assessment. The downside in this case is that these RCTs include only people who are otherwise healthy except for relatively mild winter flu." Debora MacKenzie, New Scientist
  10. "Does Tamiflu have any meaningful effects on the prevention or treatment of influenza?" Scott Gavura, Science-Based Medicine